- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.03. | LGM Pharma Commits an Additional $9M to its Texas and Colorado Facilities | ||
| 18.03. | Kupando Secures €10M More in Series A Funding for Oncology, Infectious Disease Programs | ||
| 18.03. | Excalipoint Therapeutics Launches, Will Develop Next-Gen T-Cell Engagers | ||
| 18.03. | Samsung Bioepis, Sandoz Ink Licensing Agreement for Up to Five Biosimilars | ||
| 18.03. | Oxford Biomedica Signs Licensing Deal with Australia's VVMF | ||
| 18.03. | Green Elephant Biotech Introduces Archimedes One for Cell Therapy Manufacturing | ||
| 18.03. | IsomAb Appoints Dr. Philip Brainin as Chief Executive Officer | ||
| 18.03. | Aptamer Group Introduces Targeted Radiopharmaceutical Program | ||
| 17.03. | Terumo BCT, Taiwan Bio to Advance Treg Manufacturing onto Automated Platform | ||
| 17.03. | Axplora Expands Farmabios Site in Gropello Cairoli | ||
| 17.03. | SK pharmteco Completes Regulatory Inspection of La Porte Facility | ||
| 17.03. | Alchemab Appoints Ulrich Wendt as Chief Business Officer | ||
| 17.03. | Alebund Pharmaceuticals, R1 Therapeutics Partner to Advance AP306 Outside China | ||
| 16.03. | Piramal Pharma Solutions Completes 1,500th ADC Batch at Grangemouth Facility | ||
| 16.03. | Sentynl to License Investigational Molecule from PRG S&T for Progeria Treatment | ||
| 16.03. | Celltrion's Avtozma Available in Subcutaneous Formulation for US Patients | ||
| 16.03. | Sartorius Launches Eveo Cell Therapy Platform | ||
| 16.03. | Samsung Bioepis, Epis NexLab Partner with G2GBIO to Develop Novel Semaglutide Assets | ||
| 16.03. | Korsana Biosciences Taps Dr. Mark Vignola as CFO | ||
| 13.03. | Aptar Pharma, COVIRIX Medical Partner on Inhaled Antiviral Treatments | ||
| 13.03. | Verista Acquires Integral Solutions | ||
| 13.03. | Grail Inc. Announces CEO Transition | ||
| 12.03. | Lilly to Invest $3B to Expand GLP-1 Manufacturing Capacity in China | ||
| 12.03. | Valanx Biotech Secures €3 million in Latest Round of Financing | ||
| 12.03. | Halozyme Taps David Ramsay as Interim Chief Financial Officer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.